Prospective, Randomized, Open-Label Phase II Trial on Concomitant Intraventricular Fibrinolysis and Low-Frequency Rotation After Severe Subarachnoid Hemorrhage | Zendy

Nima Etminan | Zendy; Kerim Beseoglu | Zendy; Sven Oliver Eicker | Zendy; Bernd Turowski | Zendy; HansJakob Steiger | Zendy; Daniel Hänggi | Zendy

Open Access

Prospective, Randomized, Open-Label Phase II Trial on Concomitant Intraventricular Fibrinolysis and Low-Frequency Rotation After Severe Subarachnoid Hemorrhage

Author(s) -

Nima Etminan,

Kerim Beseoglu,

Sven Oliver Eicker,

Bernd Turowski,

HansJakob Steiger,

Daniel Hänggi

Publication year - 2013

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.001790

Subject(s) - medicine , fibrinolysis , subarachnoid hemorrhage , concomitant , intraventricular hemorrhage , randomized controlled trial , open label , endovascular treatment , anesthesia , fibrinolytic agent , stroke (engine) , surgery , tissue plasminogen activator , aneurysm , genetics , pregnancy , biology , gestational age , mechanical engineering , engineering

The goal of this randomized, open-label phase II study was to investigate the effect of concomitant low-frequency head-motion therapy and intraventricular fibrinolysis in patients after surgical or endovascular treatment for aneurysmal subarachnoid hemorrhage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research